ABT vs MRK

A side-by-side look at ABT and MRK, updated throughout the trading session.

ABTABT Open ABT on Vela

MRKMRK Open MRK on Vela

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…

Live figures are refreshing. Check back in a moment.

ABT vs MRK: how they differ

Abbott Laboratories (ABT) and Merck & Co., Inc. (MRK) are both in the Healthcare sector: ABT is classified in Medical - Devices, MRK in Drug Manufacturers - General. Both trade on NYSE.

ABT trades about 10.5 million shares a day on average, against 10.3 million for MRK. ABT has the higher beta (0.58 against 0.22 for MRK), meaning it has historically moved more with the broad market. Over the trailing twelve months, ABT paid $2.52 per share in dividends and MRK paid $3.40 per share.

Figures as of October 25, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.